Mylan Races To Launch Generic Norvasc
Just a day after a court ruled its rival's patent invalid, Mylan Laboratories has rushed to launch a generic version of Pfizer Inc's blockbuster drug Norvasc....To view the full article, register now.
Already a subscriber? Click here to view full article